TeraFlu from influenza and colds 10s powder for oral solution pack.
- $12.30
Sku:
cd35f740d5c1
Brand:
Tamar Orleans (France)
The instruction
for medical use
of TeraFlyu medicine from flu and cold
the Trade name
to TeraFl from flu and cold
the International unlicensed name
Is not present
the Dosage form
Powder for preparation of solution for intake the dosed
Structure
One bag contains
active agents:
paracetamol of 325 mg,
pheniramine maleate of 20 mg,
Phenylephrinum hydrochloride of 10 mg,
ascorbic acid of 50 mg,
excipients: citrate sodium dihydrate, malic acid, yellow quinolinic (E 104), yellow Sunset (E 110), sucrose, titan dioxide (E 171), fragrance lemon 3201, calcium phosphate trekhosnovny, anhydrous citric acid.
The description
the Coarse-grained loose white granulated powder with yellow impregnations with a citrus smell. The maintenance of soft lumps
Pharmacotherapeutic group
Analgetics is allowed. Analgetics - antipyretics others. Anilides. Paracetamol in a combination with other drugs (excepting psikholeptik)
the ATX N02BE51 Code
the Pharmacological
The Combined Drug properties, possesses the febrifugal, anti-inflammatory, antiedematous, anesthetizing, antiallergic action.
Indications
- short-term symptomatic treatment of the infectious and inflammatory diseases (a SARS, flu) which are followed by high temperature, a strong fever, an ache is obese, head and muscular pain, cold, congestion of a nose, sneezing.
Route of administration and doses
Inside. To dissolve contents of one bag in 1 glass of boiled hot water. To use hot. It is possible to add sugar to taste.
It is possible to accept a repeated dose every 4-6 hours (no more than 3 doses within 24 hours).
TeraFlya from flu and cold can be applied at any time, but the best effect brings administration of drug before going to bed, for the night. If relief of symptoms within 3 days after the beginning of administration of drug is not observed, it is necessary to see a doctor.
Side effects
- are possible allergic reactions (rash, an itching, urticaria, a Quincke's disease)
- hyperexcitability
- reduction in the rate of psychomotor reactions
- feeling of fatigue
- dryness in a mouth
- an urination delay
- nausea, vomiting, stomach aches, constipations, diarrhea, a meteorism
- tachycardia, a cardiopalmus, increase in arterial blood pressure
- drowsiness, dizziness, a headache, a sleep disorder
- a mydriasis, accommodation paresis, increase in intraocular pressure.
Considering presence of paracetamol: disturbances of a system of blood (anemia, thrombocytopenia, a leukopenia, an agranulocytosis) are seldom noted, at long reception of high doses the hepatotoxic and nephrotoxic action, hemolytic anemia, a methemoglobinemia, a pancytopenia are possible, the asthmatic attack is possible, fenileferin can cause reflex bradycardia, the mydriasis, pheniramine causes the complicated urination, xerophthalmus, from the central nervous system the development change of behavior, paroxysms, diskineziya, a coma is possible.
Contraindications to use
- hypersensitivity to separate components of drug
- heavy degree of cardiovascular diseases
- blood diseases, congenital hyperbilirubinemias (Gilbert's syndromes, the Cudgel Johnson and Roterum)
- portal hypertensia, arterial hypertension
- a serious illness of a liver or kidneys, a renal failure
- diabetes
- closed-angle glaucoma
- pulmonary diseases (including bronchial asthma)
- difficulties of urination in prostate adenoma
- a contracture (stenosis) of a neck of a bladder
- a piloroduodenalny stenosis
- a peptic ulcer
- deficiency of enzyme glyukozo-6-fosfatdegidrogenazy
- epilepsy
- alcoholism
- pregnancy, the lactation period
- children's and teenage age up to 18 years.
Medicinal interactions
It is recommended to refrain from administration of drug during treatment by monoaminooxidase inhibitors. The risk of hepatotoxic action of paracetamol increases at co-administration of barbiturates, dipheninum, carbamazepine, rifampicin, a zidovudine and other inductors of microsomal enzymes of a liver.
Strengthens effect of sedatives, ethanol. Ethanol strengthens sedative effect of pheniramine. Antidepressants, protivoparkinsonichesky and antipsychotic means, fenotiazinovy derivatives increase risk of development of an ischuria, dryness in a mouth, constipations.
The concomitant use of paracetamol and non-steroidal anti-inflammatory drugs (NPVP) can potentially increase risk of the renal side effects caused by NPVP.
Fenileferin can have undesirable interaction with monoaminooxidase inhibitors, and - blockers, antihistamines like fenotiazin, broncholitic adrenomimetika, tritsiklicheskimy antidepressants, guanetidiny or atropine, a digitalis, Rauwolfia alkaloids, indometacin, metildopy, stimulators of central nervous system and theophylline. The increased pressor effect in combination with oxytoxic means can be observed. When using some anesthetics of systemic effect the development of arrhythmia is seldom possible.
Antihistamines of the first generation, such as pheniramine, can increase effect of depressants of the central nervous system (inhibitors of a monoaminooxidase, tricyclic antidepressants, alcohol, drugs against Parkinson's disease, barbiturates, tranquilizers and drugs).
Pheniramine slows down effect of anticoagulants and enters interaction with progesterone, reserpine and thiazide diuretics. Oral contraceptives can reduce efficiency of antihistamines.
Special instructions
it is not necessary to use medicine in the damaged bags, it is impossible to exceed the recommended dose and to take the drug more than 3 days.
In order to avoid toxic damage of a liver, drug should not be combined with use of alcoholic beverages.
The high doses of paracetamol received for a long time can cause an analgetic nephropathy with an irreversible liver failure.
In the presence of a prostatauxe and diseases of a thyroid gland drug should be taken with caution. Fenileferin can yield false positive result at doping control at athletes.
Because of possible vasoconstrictive effect of Phenylephrinum this drug should be used with care to patients 70 years are more senior.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
At administration of drug is not recommended to drive the car or other mechanisms as drug can cause the drowsiness amplifying at intake of tranquilizers and demulcents.
Overdose
Symptoms: drowsiness, disturbing initiation, a visual disturbance, a headache, disturbance of blood circulation, a spasm, change in behavior, increase in arterial blood pressure, bradycardia, nausea, vomiting, pains in epigastric area, hepatotoxic and nephrotoxic action, in hard cases develops a liver failure, encephalopathy and coma.
Treatment: gastric lavage, activated carbon in the first 6 h, introduction of donators of SH-group and predecessors of synthesis of glutathione-methionine in 8-9 h after overdose and N-of Acetylcysteinum in 12 h. Symptomatic therapy.
The form of release and packing
place Powder in bags from the combined material (paper/polyethyleneterephthalate/polyethylene of low density / aluminum foil / polyethylene of low density) or (polyethyleneterephthalate/polyethylene of low density / aluminum foil / polyethylene of low density).
On 10 bags together with the instruction for medical use in the state and Russian languages put in a pack from cardboard.
To Store storage conditions at a temperature not higher than 25 Pages.
To store out of children's reach!
A period of storage
2 years
Prescription status
Without prescription
the Name and the country
of the Famar Orleans manufacturing organization,
France 45071 of Orleans Sede 02, France
the Name and the country of the owner of the registration certificate
of Novartis Konsyyumer Hels SA, Switzerland
the Name and the country
of the Famar Orleans organization packer, France
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from the consumer on quality of a product
of Filial Novartis Pharm Services AG in RK
Almaty, Luganskogo St., 96
ph. (727) 258-33-03
fax: (727) 258-33-03
To develop
for medical use
of TeraFlyu medicine from flu and cold
the Trade name
to TeraFl from flu and cold
the International unlicensed name
Is not present
the Dosage form
Powder for preparation of solution for intake the dosed
Structure
One bag contains
active agents:
paracetamol of 325 mg,
pheniramine maleate of 20 mg,
Phenylephrinum hydrochloride of 10 mg,
ascorbic acid of 50 mg,
excipients: citrate sodium dihydrate, malic acid, yellow quinolinic (E 104), yellow Sunset (E 110), sucrose, titan dioxide (E 171), fragrance lemon 3201, calcium phosphate trekhosnovny, anhydrous citric acid.
The description
the Coarse-grained loose white granulated powder with yellow impregnations with a citrus smell. The maintenance of soft lumps
Pharmacotherapeutic group
Analgetics is allowed. Analgetics - antipyretics others. Anilides. Paracetamol in a combination with other drugs (excepting psikholeptik)
the ATX N02BE51 Code
the Pharmacological
The Combined Drug properties, possesses the febrifugal, anti-inflammatory, antiedematous, anesthetizing, antiallergic action.
Indications
- short-term symptomatic treatment of the infectious and inflammatory diseases (a SARS, flu) which are followed by high temperature, a strong fever, an ache is obese, head and muscular pain, cold, congestion of a nose, sneezing.
Route of administration and doses
Inside. To dissolve contents of one bag in 1 glass of boiled hot water. To use hot. It is possible to add sugar to taste.
It is possible to accept a repeated dose every 4-6 hours (no more than 3 doses within 24 hours).
TeraFlya from flu and cold can be applied at any time, but the best effect brings administration of drug before going to bed, for the night. If relief of symptoms within 3 days after the beginning of administration of drug is not observed, it is necessary to see a doctor.
Side effects
- are possible allergic reactions (rash, an itching, urticaria, a Quincke's disease)
- hyperexcitability
- reduction in the rate of psychomotor reactions
- feeling of fatigue
- dryness in a mouth
- an urination delay
- nausea, vomiting, stomach aches, constipations, diarrhea, a meteorism
- tachycardia, a cardiopalmus, increase in arterial blood pressure
- drowsiness, dizziness, a headache, a sleep disorder
- a mydriasis, accommodation paresis, increase in intraocular pressure.
Considering presence of paracetamol: disturbances of a system of blood (anemia, thrombocytopenia, a leukopenia, an agranulocytosis) are seldom noted, at long reception of high doses the hepatotoxic and nephrotoxic action, hemolytic anemia, a methemoglobinemia, a pancytopenia are possible, the asthmatic attack is possible, fenileferin can cause reflex bradycardia, the mydriasis, pheniramine causes the complicated urination, xerophthalmus, from the central nervous system the development change of behavior, paroxysms, diskineziya, a coma is possible.
Contraindications to use
- hypersensitivity to separate components of drug
- heavy degree of cardiovascular diseases
- blood diseases, congenital hyperbilirubinemias (Gilbert's syndromes, the Cudgel Johnson and Roterum)
- portal hypertensia, arterial hypertension
- a serious illness of a liver or kidneys, a renal failure
- diabetes
- closed-angle glaucoma
- pulmonary diseases (including bronchial asthma)
- difficulties of urination in prostate adenoma
- a contracture (stenosis) of a neck of a bladder
- a piloroduodenalny stenosis
- a peptic ulcer
- deficiency of enzyme glyukozo-6-fosfatdegidrogenazy
- epilepsy
- alcoholism
- pregnancy, the lactation period
- children's and teenage age up to 18 years.
Medicinal interactions
It is recommended to refrain from administration of drug during treatment by monoaminooxidase inhibitors. The risk of hepatotoxic action of paracetamol increases at co-administration of barbiturates, dipheninum, carbamazepine, rifampicin, a zidovudine and other inductors of microsomal enzymes of a liver.
Strengthens effect of sedatives, ethanol. Ethanol strengthens sedative effect of pheniramine. Antidepressants, protivoparkinsonichesky and antipsychotic means, fenotiazinovy derivatives increase risk of development of an ischuria, dryness in a mouth, constipations.
The concomitant use of paracetamol and non-steroidal anti-inflammatory drugs (NPVP) can potentially increase risk of the renal side effects caused by NPVP.
Fenileferin can have undesirable interaction with monoaminooxidase inhibitors, and - blockers, antihistamines like fenotiazin, broncholitic adrenomimetika, tritsiklicheskimy antidepressants, guanetidiny or atropine, a digitalis, Rauwolfia alkaloids, indometacin, metildopy, stimulators of central nervous system and theophylline. The increased pressor effect in combination with oxytoxic means can be observed. When using some anesthetics of systemic effect the development of arrhythmia is seldom possible.
Antihistamines of the first generation, such as pheniramine, can increase effect of depressants of the central nervous system (inhibitors of a monoaminooxidase, tricyclic antidepressants, alcohol, drugs against Parkinson's disease, barbiturates, tranquilizers and drugs).
Pheniramine slows down effect of anticoagulants and enters interaction with progesterone, reserpine and thiazide diuretics. Oral contraceptives can reduce efficiency of antihistamines.
Special instructions
it is not necessary to use medicine in the damaged bags, it is impossible to exceed the recommended dose and to take the drug more than 3 days.
In order to avoid toxic damage of a liver, drug should not be combined with use of alcoholic beverages.
The high doses of paracetamol received for a long time can cause an analgetic nephropathy with an irreversible liver failure.
In the presence of a prostatauxe and diseases of a thyroid gland drug should be taken with caution. Fenileferin can yield false positive result at doping control at athletes.
Because of possible vasoconstrictive effect of Phenylephrinum this drug should be used with care to patients 70 years are more senior.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
At administration of drug is not recommended to drive the car or other mechanisms as drug can cause the drowsiness amplifying at intake of tranquilizers and demulcents.
Overdose
Symptoms: drowsiness, disturbing initiation, a visual disturbance, a headache, disturbance of blood circulation, a spasm, change in behavior, increase in arterial blood pressure, bradycardia, nausea, vomiting, pains in epigastric area, hepatotoxic and nephrotoxic action, in hard cases develops a liver failure, encephalopathy and coma.
Treatment: gastric lavage, activated carbon in the first 6 h, introduction of donators of SH-group and predecessors of synthesis of glutathione-methionine in 8-9 h after overdose and N-of Acetylcysteinum in 12 h. Symptomatic therapy.
The form of release and packing
place Powder in bags from the combined material (paper/polyethyleneterephthalate/polyethylene of low density / aluminum foil / polyethylene of low density) or (polyethyleneterephthalate/polyethylene of low density / aluminum foil / polyethylene of low density).
On 10 bags together with the instruction for medical use in the state and Russian languages put in a pack from cardboard.
To Store storage conditions at a temperature not higher than 25 Pages.
To store out of children's reach!
A period of storage
2 years
Prescription status
Without prescription
the Name and the country
of the Famar Orleans manufacturing organization,
France 45071 of Orleans Sede 02, France
the Name and the country of the owner of the registration certificate
of Novartis Konsyyumer Hels SA, Switzerland
the Name and the country
of the Famar Orleans organization packer, France
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from the consumer on quality of a product
of Filial Novartis Pharm Services AG in RK
Almaty, Luganskogo St., 96
ph. (727) 258-33-03
fax: (727) 258-33-03
To develop
Related Products
